National News

FILE -- The headquarters of the biotech company Regeneron in Tarrytown, N.Y., June 29, 2020. The Food and Drug Administration has granted emergency authorization for an experimental antibody treatment made by Regeneron and given to President Trump shortly after he was diagnosed with Covid-19. (Melissa Bunni Elian/The New York Times)